CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,520,918
+$20,178,401 QoQ
Shares Held
1,322,613
+2.6% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#28
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. HALO ranks #16 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in HALO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,520,918 | 1,322,613 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $83,342,517 | 1,289,533 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $83,575,091 | 1,241,829 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $92,509,242 | 1,261,375 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $69,854,068 | 1,342,831 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $111,594,182 | 1,748,851 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $85,253,692 | 1,783,177 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $101,509,244 | 1,773,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $93,596,013 | 1,787,548 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $67,833,045 | 1,667,479 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $64,167,069 | 1,736,122 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $64,877,313 | 1,698,359 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $60,686,223 | 1,682,457 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $64,387,385 | 1,685,975 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $91,780,041 | 1,613,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $63,682,293 | 1,610,579 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,348,348 | 1,257,917 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $52,848,856 | 1,325,197 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,056,469 | 1,294,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $53,472,476 | 1,314,466 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $55,819,924 | 1,229,243 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,704,574 | 1,144,269 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $40,408,486 | 946,113 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $24,869,210 | 946,317 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $23,999,266 | 895,161 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $15,266,565 | 848,614 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||